With a history of more than 100 years, radiation therapy remains one of the main modalities used in the management of cancer together with surgery and chemotherapy.

The progress in treatment planning, image guidance and radiation delivery has led to the appearance of high precision radiotherapy that is a common feature in many clinics. Furthermore, the technological development of functional and molecular techniques for imaging the tumours has opened new possibilities for defining the target and devising the treatment in an innovative manner.

However important questions remain with respect to the relevant clinical and radiobiological aspects.

For radiobiology in particular, progress in research is not accompanied by a quick clinical implementation in spite of its translational character.

Classical radiobiology with its famous 5 R’s and the linear-quadratic model for clonogenic survival has been the most influential component of the radiotherapy fractionation schedule design and calculations of isoeffects, while some modern findings do not easily find their way from bench to bedside.

This workshop aims to revisit the old school of radiobiology and identify new findings that have potential to impact on the clinical practice and lead towards the next big leap in clinical radiotherapy: the development of high precision individualised radiotherapy.

The workshop is based on presentations by invited speakers. Registered participants are welcome to submit electronic posters (e-posters) that will be made available on this webpage.